Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Graphene-Based Multifunctional Nano Systems for Breast Cancer Detection and Therapy

Jaleh Adibkia

Graphene-based multifunctional nanosystems have emerged as promising tools in the field of breast cancer detection and therapy. Breast cancer remains a significant global health concern, necessitating the development of innovative approaches to enhance early diagnosis and effective treatment. Graphene, with its exceptional electrical, mechanical, and biocompatible properties, offers a unique platform for the design of multifunctional nanosystems that can simultaneously detect and combat breast cancer. This review explores the recent advances in graphenebased nanosystems designed for breast cancer applications. It discusses the utilization of graphene’s superior properties for enhanced imaging and diagnosis, focusing on early-stage detection through the integration of various imaging modalities. Additionally, the review covers the integration of therapeutic agents such as chemotherapeutic drugs, gene therapies, and photothermal agents onto graphene-based nanocarriers, showcasing their potential for targeted therapy and minimizing off-target effects. The multifunctional nature of these nanosystems allows for the development of personalized and precision medicine approaches tailored to the specific characteristics of each patient’s breast cancer. Furthermore, the review highlights the challenges and prospects associated with graphenebased nanosystems, including biocompatibility, safety, and scalability.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.